Suchergebnisse - "Nayak, Rahul K"

PubPharm (20)

1

SOHO State of the Art Updates and Next Questions | Immunotherapeutic Options for Patients With Mantle Cell Lymphoma Who Progress on BTK Inhibitors

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Nayak, R. | Gerber, D. | Zhang, C. | +1

2

340B-Where Do We Go From Here?

enthalten in: JAMA | 2023

von Kishore, S. | Nayak, R. | Kesselheim, A.

3

The Inflation Reduction Act : How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?

enthalten in: Current cardiology reports | 2023

von Johnson, M. | Kishore, S. | Nayak, R. | +1

4

The Inflation Reduction Act: How Will Medicare Negotiating Drug Prices Impact Patients with Heart Disease?

enthalten in: Current cardiology reports | 2023

von Johnson, M. | Kishore, S. | Nayak, R. | +1

5

Estimation of Out-of-Pocket Costs for Guideline-Directed Medical Therapy for Heart Failure Under Medicare Part D and the Inflation Reduction Act

enthalten in: JAMA cardiology | 2023

von Johnson, M. | Nayak, R. | Gilstrap, L. | +1

6

Maintenance therapy for AML after allogeneic HCT

enthalten in: Frontiers in oncology | 2022

von Nayak, R. | Chen, Y.

7

Financial toxicity in cancer care : origins, impact, and solutions

enthalten in: Translational behavioral medicine | 2021

von Abrams, H. | Durbin, S. | Huang, C. | +4

8

Public-sector Contributions to Novel Biologic Drugs

enthalten in: JAMA internal medicine | 2021

von Nayak, R. | Lee, C. | Avorn, J. | +1

9

Cognitive Tests and Stool Frequency at Hospital Discharge Do Not Predict Outcomes in Hepatic Encephalopathy

enthalten in: Southern medical journal | 2020

von Bloom, P. | Miller, S. | Nayak, R. | +4

10

Public sector financial support for late stage discovery of new drugs in the United States : cohort study

enthalten in: BMJ (Clinical research ed.) | 2019

von Nayak, R. | Avorn, J. | Kesselheim, A.